Versatope Therapeutics
Dr. Kuo has over 25 years of experience in senior leadership roles in pharmaceutical business development. He has played key roles in leading venture capital financing, strategic partnerships, licensing and strategic planning in the genomics, small molecule, biotherapy, monoclonal antibody and inflammatory disease. He is currently the Chairman of the Board of Immunoprecise Antibodies and Monarch Labs.
This person is not in the org chart
This person is not in any offices
Versatope Therapeutics
Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.